PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, CDMX, 04510, Mexico City, Mexico.\', \'Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, CDMX, 04510, Mexico City, Mexico. sersan@biomedicas.unam.mx.\', \'Charles A. Dana Research Institute for Scientists Emeriti (R.I.S.E.), Drew University, Madison, NJ, 07940, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00253-022-11821-5
?:doi
?:hasPublicationType
?:journal
  • Applied microbiology and biotechnology
is ?:pmid of
?:pmid
?:pmid
  • 35188588
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.182
?:rankingScore_hIndex
  • 188
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of novel microbial secondary metabolites on the pharma industry.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35188588>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35188588>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all